Human Immunodeficiency Virus Type 1 Vif Is Efficiently Packaged into Virions during Productive but Not Chronic Infection
Open Access
- 15 January 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (2) , 1131-1140
- https://doi.org/10.1128/jvi.77.2.1131-1140.2003
Abstract
Packaging of the human immunodeficiency virus type 1 Vif protein into virus particles is mediated through an interaction with viral genomic RNA and results in the association of Vif with the nucleoprotein complex. Despite the specificity of this process, calculations of the amount of Vif packaged have produced vastly different results. Here, we compared the efficiency of packaging of Vif into virions derived from acutely and chronically infected H9 cells. We found that Vif was efficiently packaged into virions from acutely infected cells (60 to 100 copies per virion), while packaging into virions from chronically infected H9 cells was near the limit of detection (four to six copies of Vif per virion). Superinfection by an exogenous Vif-defective virus did not rescue packaging of endogenous Vif expressed in the chronically infected culture. In contrast, exogenous Vif expressed by superinfection of wild-type virus was readily packaged (30 to 40 copies per virion). Biochemical analyses suggest that the differences in the relative packaging efficiencies were not due to gross differences in the steady-state distribution of Vif in chronically or acutely infected cells but are likely due to differences in the relative rates of de novo synthesis of Vif. Despite its low packaging efficiency, endogenously expressed Vif was sufficient to direct the production of viruses with almost wild-type infectivity. The results from our study provide novel insights into the biochemical properties of Vif and offer an explanation for the reported differences regarding Vif packaging.Keywords
This publication has 106 references indexed in Scilit:
- Intravirion Processing of the Human Immunodeficiency Virus Type 1 Vif Protein by the Viral Protease May Be Correlated with Vif FunctionJournal of Virology, 2002
- Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinNature, 2002
- Envelope Glycoprotein Incorporation, Not Shedding of Surface Envelope Glycoprotein (gp120/SU), Is the Primary Determinant of SU Content of Purified Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency VirusJournal of Virology, 2002
- Human Immunodeficiency Virus Type 1 Vif Protein Is Packaged into the Nucleoprotein Complex through an Interaction with Viral Genomic RNAJournal of Virology, 2001
- The Multimerization of Human Immunodeficiency Virus Type I Vif ProteinJournal of Biological Chemistry, 2001
- The Redox State of Cysteines in Human Immunodeficiency Virus Type 1 Vif in Infected Cells and in VirionsBiochemical and Biophysical Research Communications, 1997
- The Human Immunodeficiency Virus Type 1 (HIV-1) Vif Protein Is Located in the Cytoplasm of Infected Cells and Its Effect on Viral Replication Is Equivalent in HIV-2AIDS Research and Human Retroviruses, 1993
- Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cellsArchiv für die gesamte Virusforschung, 1992
- Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic virusesJournal of General Virology, 1992
- The sor Gene of HIV-1 Is Required for Efficient Virus Transmission in VitroScience, 1987